News Conference News The Structural Heart Disease Summit 2018 Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli Michael O'Riordan June 26, 2018
News Conference News The Structural Heart Disease Summit 2018 PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial Shelley Wood June 23, 2018
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
Presentation The Structural Heart Disease Summit 2018 The Minimalist TAVR Strategy Should be the Default Approach Supported by Clinical Outcomes and Economic Benefits Presenter: Vinod H. Thourani, John G. Webb June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions Shelley Wood June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A) Presenter: Francesco Maisano June 22, 2018
Presentation The Structural Heart Disease Summit 2018 The Epicardial Approach: Lariat Indications, Technique, Outcomes, and Ongoing Studies Presenter: Shephal Doshi, Josep Rodés-Cabau, Steven J. Yakubov June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients Presenter: William A. Gray, Gregg W. Stone, DJ Lakkireddy June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries Presenter: William A. Gray, Gregg W. Stone, Matthew J. Price June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Perspectives From the STS/ACC TVT Registry: Factors That Impact Clinical Outcomes Presenter: Michael J. Mack, John D. Carroll June 21, 2018
Presentation The Structural Heart Disease Summit 2018 "Traditional Open" and "Transcatheter Open" Surgical Approaches to Patients With MAC and MS/MR: Techniques and Outcomes Presenter: Mayra Guerrero, Vinod H. Thourani, Isaac George June 21, 2018
News Conference News The Structural Heart Disease Summit 2018 Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year Michael O'Riordan June 21, 2018
Presentation The Structural Heart Disease Summit 2018 CASE Examples: Using LAMPOON to Optimize Outcomes in Difficult Transcatheter Mitral Valve Patients Presenter: Mayra Guerrero, Lars Sondergaard, Adam B. Greenbaum June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes Presenter: Azeem Latib June 21, 2018
Presentation The Structural Heart Disease Summit 2018 TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients Presenter: John C Laschinger, Mathew Williams, Jung-Min Ahn June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The Rapid Emergence of Transcaval TAVR: Techniques and Clinical Outcomes Presenter: Adam B. Greenbaum June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes Presenter: Vinayak Bapat, Ran Kornowski, Danny Dvir June 21, 2018
Video » SHDS 2018: Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A) July 4, 2018